本文選題：胃癌　切入點(diǎn)：腫瘤相關(guān)成纖維細(xì)胞　出處：《浙江大學(xué)》2016年博士論文　論文類型：學(xué)位論文

【摘要】：背景：胃癌是全球最常見的惡性腫瘤之一,其發(fā)病率位居第四,腫瘤相關(guān)死亡率位居第二。腫瘤血管形成促進(jìn)腫瘤生長和轉(zhuǎn)移,VEGF/VEGFR信號通路在腫瘤血管生成中起主導(dǎo)作用。因此抗腫瘤血管生成治療多以VEGF/VEGFR為靶點(diǎn)。Apatinib作為VEGFR抑制劑,晚期胃癌患者接受apatinib治療使生存獲益,但是缺乏能夠預(yù)測apatinib獲益人群的生物標(biāo)志物。腫瘤相關(guān)成纖維細(xì)胞(cancer-associated fibroblasts, CAFs)分泌多種細(xì)胞因子促進(jìn)腫瘤血管生成。Galectin-1在腫瘤細(xì)胞和CAFs中均可表達(dá)。近年來,多項(xiàng)研究報(bào)道galectin-1通過多種途徑促進(jìn)腫瘤血管生成。然而,galectin-1在CAFs中表達(dá)與胃癌apatinib敏感性的關(guān)系,目前尚無報(bào)道。第一部分：研究背景：腫瘤進(jìn)展是腫瘤細(xì)胞和CAFs相互促進(jìn)的結(jié)果,腫瘤細(xì)胞分泌的細(xì)胞因子如TGF-p等,誘導(dǎo)正常成纖維細(xì)胞(normal fibroblasts, NFs)向CAFs轉(zhuǎn)化,而CAFs活化后促進(jìn)腫瘤進(jìn)展。Galectin-1在腫瘤細(xì)胞和CAFs均可表達(dá)。目前galectin-1/TGF-β信號軸在腫瘤細(xì)胞與CAFs相互促進(jìn)過程中所起的中介作用尚不清楚,因此我們將對galectin-1/TGF-β在腫瘤細(xì)胞與CAFs間所起的聯(lián)系進(jìn)行探索。方法：分離原代胃癌CAFs和NFs,并應(yīng)用免疫熒光和western blotting進(jìn)行鑒定。應(yīng)用real-time PCR和western blotting比較CAFs和NFs中g(shù)alectin-1的表達(dá)水平。利用galectin-1過表達(dá)的慢病毒載體感染NFs上調(diào)galectin-1表達(dá)(NFs-Gall), Small interfering RNA (siRNA)轉(zhuǎn)染CAFs沉默galectin-1表達(dá)(CAFs-siGal1)。通過腫瘤細(xì)胞上清液誘導(dǎo)NFs向CAFs轉(zhuǎn)化的模型,探索galectin-1/TGF-β信號軸在腫瘤細(xì)胞與CAFs相互作用中的聯(lián)系。免疫組織化學(xué)法檢測胃癌組織中g(shù)alectin-1、TGF-β的表達(dá)情況,明確galectin-1與TGF-β的關(guān)聯(lián)。Kaplan-Meier曲線描述胃癌患者的生存期,并采用Log-rank檢驗(yàn)對臨床資料和數(shù)據(jù)進(jìn)行統(tǒng)計(jì)分析。Cox regression風(fēng)險(xiǎn)回歸模型對胃癌預(yù)后的各臨床參數(shù)進(jìn)行多因素分析。結(jié)果：Galectin-1在CAFs中高表達(dá),并且促進(jìn)NFs向CAFs轉(zhuǎn)化。腫瘤細(xì)胞分泌TGF-β誘導(dǎo)NFs表達(dá)galectin-1, galectin-1正向調(diào)節(jié)TGF-β誘發(fā)的NFs向CAFs轉(zhuǎn)化。Galectin-1表達(dá)與TGF-β表達(dá)呈正相關(guān)(r= 0.765, P0.001)。Galectin-1表達(dá)水平與腫瘤分化程度、淋巴轉(zhuǎn)移、浸潤深度和腫瘤TNM分期有關(guān)。Galectin-1高表達(dá)的胃癌患者總生存期短,并且是獨(dú)立的預(yù)后因素。結(jié)論：Galectin-1促進(jìn)TGF-p所誘導(dǎo)的NFs向CAFs轉(zhuǎn)化的過程,并且其表達(dá)水平與胃癌患者的預(yù)后呈負(fù)相關(guān)。第二部分研究背景：第一部分實(shí)驗(yàn)結(jié)果表明CAFs中g(shù)alectin-1表達(dá)升高,并且galectin-1表達(dá)水平與胃癌患者預(yù)后呈負(fù)相關(guān)。我們將通過一系列的體外體內(nèi)功能學(xué)實(shí)驗(yàn)探索galectin-1促進(jìn)腫瘤進(jìn)展的機(jī)制。方法：通過不同Galectin-1表達(dá)水平的成纖維細(xì)胞條件培養(yǎng)基(CMs)培養(yǎng)胃癌細(xì)胞,采用流式細(xì)胞儀(flow cytometry, FC)檢測腫瘤細(xì)胞凋亡,transwell實(shí)驗(yàn)檢測腫瘤細(xì)胞侵襲和遷移。Western blotting等實(shí)驗(yàn)方法對作用機(jī)制進(jìn)行探討。建立裸鼠皮下荷瘤模型,明確成纖維細(xì)胞galectin-1表達(dá)水平對腫瘤生長的影響。結(jié)果：CAFs明顯抑制腫瘤細(xì)胞凋亡,促進(jìn)侵襲和遷移(P0.05)。沉默CAFs中g(shù)alectin-1表達(dá),抗腫瘤細(xì)胞凋亡及促侵襲的作用被逆轉(zhuǎn)。CAFs促進(jìn)腫瘤細(xì)胞中Bcl-2和MMP9表達(dá),抑制Bax表達(dá)。裸鼠荷瘤實(shí)驗(yàn)結(jié)果顯示,galectin-1高表達(dá)的成纖維細(xì)胞明顯促進(jìn)腫瘤生長。結(jié)論：Galectin-1高表達(dá)的CAFs通過調(diào)節(jié)凋亡相關(guān)蛋白和MMP9的表達(dá)水平,分別影響腫瘤細(xì)胞凋亡、侵襲和轉(zhuǎn)移的過程。第三部分研究背景：Apatinib靶向VEGFR,使晚期胃癌患者的生存顯著獲益,但是缺乏能夠預(yù)測apatinib療效的生物標(biāo)志物。Galectin-1在腫瘤血管生成中起重要作用,因此,我們將明確galectin-1表達(dá)水平與胃癌apatinib敏感性的關(guān)系。方法：通過CCK-8及體外HUVEC小管形成實(shí)驗(yàn),探索CAFs中g(shù)alectin-1的表達(dá)水平與apatinib敏感性的關(guān)系。NFs-Gal1、NFs-Ctr分別與腫瘤細(xì)胞共同接種,建立裸鼠皮下荷瘤模型,從體內(nèi)水平評價(jià)apatinib的療效。結(jié)果：Galectin-1促進(jìn)CAFs表達(dá)bFGF,使apatinib抑制HUVEC增殖及小管形成的作用受限。上調(diào)NFs中g(shù)alectin-1表達(dá)能夠抑制apatinib抗腫瘤生長及抗血管生成的作用。結(jié)論：Galectin-1表達(dá)導(dǎo)致apatinib耐藥的發(fā)生。
[Abstract]:Background: gastric cancer is one of the most common malignant tumor in the world, the incidence rate was fourth, tumor related mortality was second. Tumor angiogenesis and promote tumor growth and metastasis, VEGF/VEGFR signaling pathway plays a dominant role in tumor angiogenesis. Therefore, anti angiogenesis therapy targeting VEGF/VEGFR.Apatinib as a VEGFR inhibitor to survive benefit from apatinib therapy in patients with advanced gastric cancer, but the lack of biomarkers to predict apatinib benefit groups. Tumor associated fibroblasts (cancer-associated, fibroblasts, CAFs) secreting a variety of cytokines.Galectin-1 can promote tumor angiogenesis in tumor cells and CAFs expression. In recent years, several studies reported that galectin-1 promote tumor angiogenesis through a variety of ways. However, the expression of galectin-1 and gastric carcinoma apatinib sensitivity in CAFs, the current is still No reports. The first part: BACKGROUND: tumor cells and CAFs tumor progression is the result of mutual promotion, tumor cells secrete cytokines such as TGF-p, normal fibrolasts (normal fibroblasts, NFs) and transformed to CAFs, after the activation of CAFs promotes the expression of.Galectin-1 in tumor cells and tumor progression. The CAFs can be galectin-1/TGF- beta signaling axis in tumor cells and CAFs mutual promotion has a mediating effect in the process is not clear, so we will galectin-1/TGF- beta plays in tumor cells and to explore the relations between CAFs. Methods: isolated primary gastric cancer CAFs and NFs, and the application of immunofluorescence and Western blotting were used to identify the expression level of galectin-1 application. Real-time PCR and Western blotting CAFs and NFs. Using the galectin-1 Lentivirus Expression Vector NFs infection up regulates the expression of galectin-1 (NFs-Gall, Small) Interfering RNA (siRNA) transfection and expression of CAFs silencing (CAFs-siGal1) induced by NFs. Galectin-1 to CAFs conversion by the supernatant of tumor cells in tumor cell model, explore the interaction between CAFs and galectin-1/TGF- in the beta signaling axis. Immunohistochemistry was used to detect the gastric cancer tissues galectin-1, the expression of TGF- beta,.Kaplan-Meier curve galectin-1 clear association with the TGF- beta description of the survival of patients with gastric cancer, and Log-rank test was used for statistical analysis of clinical parameters of.Cox regression on the prognosis of gastric cancer risk regression model of clinical data and the data were analyzed by multivariate analysis. Results: the expression of Galectin-1 in CAFs, and promote the transformation of NFs to CAFs. The tumor cells secrete TGF- beta induced NFs expression galectin-1, transformation of galectin-1 positively regulates TGF- beta induced NFs to CAFs the expression of.Galectin-1 was positively correlated with the expression of TGF- beta (r= 0.765, P0 .001).Galectin-1 expression and tumor differentiation, lymph node metastasis, invasion depth and overall survival of patients with gastric cancer tumor TNM stage.Galectin-1 expression is short, and is an independent prognostic factor. Conclusion: Galectin-1 promotes the process of transformation induced by TGF-p NFs to CAFs, and negatively correlated with the expression level and prognosis of gastric cancer with the research background. The second part: the first part of the experiment results show that the increase of expression of galectin-1 in CAFs, and the expression level of galectin-1 was negatively correlated with prognosis in patients with gastric cancer. We will go through the function of a series of studies in vitro and in vivo experiments to explore the mechanism of galectin-1 promoting tumor progression. Methods: the different expression levels of Galectin-1 fibroblast conditioned medium (CMs) cultured gastric cancer cells by flow cytometry (flow cytometry FC) to detect the apoptosis of tumor cells, Transwell assay, tumor Cell invasion and migration of.Western blotting and other experimental methods to explore the mechanism. To establish the model of nude mice bearing tumor, clear fibroblasts galectin-1 expression level of tumor growth. Results: CAFs can significantly inhibit the apoptosis of tumor cells, promote the invasion and migration (P0.05). The expression of galectin-1 CAFs in silence, and promote the apoptosis of tumor cells the invasion effect was reversed by.CAFs promotes the expression of Bcl-2 and MMP9 in tumor cells, inhibit the expression of Bax in tumor bearing nude mice. The experimental results show that the high expression of galectin-1 fibroblasts significantly promote tumor growth. Conclusion: high expression of Galectin-1 CAFs by regulating the expression level of apoptosis related protein and MMP9, respectively. The apoptosis of tumor cells and process the invasion and metastasis. The third part is the research background: Apatinib targeting VEGFR, the survival of a significant benefit for patients with advanced gastric cancer, but the lack of able to predict APA Biomarkers.Galectin-1 effect of tinib play an important role in tumor angiogenesis, therefore, we will clear the relationship between the expression level of galectin-1 and apatinib in gastric carcinoma. Methods: the formation of sensitivity experiments by CCK-8 and in vitro HUVEC tubules,.NFs-Gal1 to explore the relationship between CAFs galectin-1 expression level and the sensitivity of apatinib, NFs-Ctr were co inoculated with tumor cells the establishment of subcutaneous xenograft model in nude mice, and evaluate the effect of apatinib from the body level. Results: Galectin-1 promotes the expression of CAFs bFGF, the role of the limited apatinib inhibits proliferation and tubule formation of HUVEC. Up regulation of NFs expression of galectin-1 in apatinib can inhibit the anti-tumor growth and anti angiogenesis effect. Conclusion: the expression of Galectin-1 apatinib lead to the occurrence of drug resistance.

【學(xué)位授予單位】：浙江大學(xué)
【學(xué)位級別】：博士
【學(xué)位授予年份】：2016
【分類號】：R735.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;Circulating galectin-3 in the bloodstream:An emerging promoter of cancer metastasis[J];World Journal of Gastrointestinal Oncology;2010年04期

2 楊婷婷;程若川;;galectin-3與幾種甲狀腺疾病的關(guān)系[J];中國普外基礎(chǔ)與臨床雜志;2011年08期

3 María L Bacigalupo;Malena Manzi;Gabriel A Rabinovich;María F Troncoso;;Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma[J];World Journal of Gastroenterology;2013年47期

4 鄭華川;王威;關(guān)一夫;平尷}一;;CCl_4誘發(fā)galectin-3基因敲除鼠急性肝損傷的實(shí)驗(yàn)研究[J];中國醫(yī)科大學(xué)學(xué)報(bào);2008年05期

5 童華生;張亞歷;姜泊;蘇磊;;galectin-1表達(dá)下調(diào)對LST-R1細(xì)胞侵襲表型的影響[J];胃腸病學(xué);2010年04期

6 張巖;佟盛春;王永來;趙潤秋;;galectin-3在子宮內(nèi)膜病變中表達(dá)的研究[J];中國醫(yī)科大學(xué)學(xué)報(bào);2008年05期

7 ;Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3[J];World Journal of Gastroenterology;2008年13期

8 童華生;張亞歷;姜泊;蘇磊;;RNAi沉默galectin-1表達(dá)對黏附LST-R1細(xì)胞生長的影響[J];胃腸病學(xué)和肝病學(xué)雜志;2009年12期

9 張延美,董娟,胡克霞;galectin-3與甲狀腺腫瘤[J];山西醫(yī)科大學(xué)學(xué)報(bào);2003年03期

10 張磊;張思瑾;常明;胡林森;;蛋白酶體抑制劑誘導(dǎo)的帕金森病模型中g(shù)alectin-1含量變化的研究[J];腦與神經(jīng)疾病雜志;2010年02期

相關(guān)會議論文 前10條

1 ;A novel fungal galectin induces apoptosis through inhibition of farnesyltransferase activity[A];湖北省生物工程學(xué)會2004年年會學(xué)術(shù)報(bào)告及論文摘要匯編[C];2004年

2 ;Galectin-3 and wound repair[A];第七屆全國創(chuàng)傷學(xué)術(shù)會議暨2009海峽兩岸創(chuàng)傷醫(yī)學(xué)論壇論文匯編[C];2009年

3 黃健;金潔;;骨髓增生異常綜合征患者galectin-3和mdr-1表達(dá)及其相關(guān)性研究[A];2012年浙江省血液病學(xué)年會論文集[C];2012年

4 張亞歷;賴卓勝;姜泊;童華生;;RNAi沉默galectin-1表達(dá)對LST-R1細(xì)胞惡性表型的影響[A];中華醫(yī)學(xué)會第七次全國消化病學(xué)術(shù)會議論文匯編（下冊）[C];2007年

5 童華生;張亞歷;姜泊;;RNAi沉默galectin-1表達(dá)對LST-R1細(xì)胞表型的影響[A];2009年全國危重病急救醫(yī)學(xué)學(xué)術(shù)會議論文匯編[C];2009年

6 張亞歷;姜泊;童華生;;RNAi沉默galectin-1表達(dá)對LST-R1細(xì)胞增殖與凋亡的影響[A];中華醫(yī)學(xué)會第七次全國消化病學(xué)術(shù)會議論文匯編（下冊）[C];2007年

7 Yufu Ye;Shen Yan;Xiaojun Xie;Shusen Zheng;;Galectin-1 Attenuates Hepatic Ischemia Reperfusion Injury in Mice through an IL-10-dependent Mechanism[A];2013中國器官移植大會論文匯編[C];2013年

8 Yufu Ye;Sheng Yan;Qiyi Zhang;Yuan Ding;Fei Sun;Yang Tian;Lin Zhou;Haiyang Xie;Shusen Zheng;;Galectin-1 Attenuates Hepatic Ischemia Reperfusion Injury in Mice through an IL-10-dependent Mechanism[A];2013年浙江省腸外腸內(nèi)營養(yǎng)學(xué)學(xué)術(shù)年會論文匯編[C];2013年

9 童華生;賴曉嶸;張亞歷;姜泊;;Galectin-1對LoVo細(xì)胞生長惡性表型的影響[A];中華醫(yī)學(xué)會第七次全國消化病學(xué)術(shù)會議論文匯編（下冊）[C];2007年

10 童華生;賴曉嶸;張亞歷;姜泊;賴卓勝;;細(xì)胞膜表面Galectin-1抗體阻斷對LST-R1細(xì)胞與Ⅰ型膠原黏附的影響[A];中華醫(yī)學(xué)會第七次全國消化病學(xué)術(shù)會議論文匯編（下冊）[C];2007年

相關(guān)博士學(xué)位論文 前7條

1 鄭玲燕;Galectin-1介導(dǎo)NFs向CAFs轉(zhuǎn)化與胃癌apatinib敏感性的關(guān)系的研究[D];浙江大學(xué);2016年

2 張濤;酸堿修飾的檸檬果膠的分離純化及其與半乳凝素-3相互作用的構(gòu)效關(guān)系研究[D];東北師范大學(xué);2016年

3 張鴻;galectin-3在CCl_4肝損傷中作用機(jī)制的研究[D];中國醫(yī)科大學(xué);2005年

4 童華生;大腸側(cè)向發(fā)育型腫瘤差異蛋白篩選及galectin-1對大腸癌細(xì)胞表型的影響[D];第一軍醫(yī)大學(xué);2006年

5 高錫強(qiáng);CD45糖基化對galectin-3結(jié)合與凋亡誘導(dǎo)的影響&感染途徑對艾滋病恒河猴CD4~+T細(xì)胞表達(dá)CD95的影響[D];北京協(xié)和醫(yī)學(xué)院;2013年

6 梁美艷;半乳糖結(jié)合蛋白（Galectin）-9抗腫瘤作用及其在子宮頸癌組織中的表達(dá)和臨床意義[D];中國醫(yī)科大學(xué);2008年

7 張榮成;蛋白標(biāo)記物在心力衰竭患者的臨床應(yīng)用[D];北京協(xié)和醫(yī)學(xué)院;2015年

相關(guān)碩士學(xué)位論文 前10條

1 顧彩紅;Tim3及其配體galectin-9在急性髓系白血病的表達(dá)及功能研究[D];蘇州大學(xué);2016年

2 張國強(qiáng);肝細(xì)胞肝癌中g(shù)alectin-9表達(dá)及其臨床意義[D];南方醫(yī)科大學(xué);2011年

3 孫婭莉;仔豬galectins基因的組織分布及斷乳前后其在胃腸道表達(dá)差異研究[D];河南農(nóng)業(yè)大學(xué);2010年

4 劉守勝;牙鲆半乳糖凝集素galectin-1的抗病毒活性研究[D];中國海洋大學(xué);2014年

5 雒真龍;Galectin-7在小鼠移植皮膚中的表達(dá)及其意義[D];華中科技大學(xué);2010年

6 郭一川;Skp2、p27、galectin-3在子宮頸上皮內(nèi)瘤變中的表達(dá)及意義[D];新疆醫(yī)科大學(xué);2008年

7 趙世彬;IVF失敗者子宮內(nèi)膜galectin-3表達(dá)及其容受性評估[D];河北醫(yī)科大學(xué);2011年

8 褚芬芬;NLRP3在高糖誘導(dǎo)HK-2細(xì)胞轉(zhuǎn)分化中的作用及其表達(dá)與galectin-1的關(guān)系[D];中南大學(xué);2014年

9 黃青;siRNA干擾大腸癌細(xì)胞株galectin-3蛋白表達(dá)的研究[D];廣州醫(yī)科大學(xué);2013年

10 徐躍;中華蟾蜍與日本蟾蜍皮膚galectin-3 cDNA的克隆、序列分析及原核表達(dá)[D];浙江農(nóng)林大學(xué);2012年

，

本文編號：1631257